Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v4-FR
Language French French
Date Updated 2022-09-16 2021-12-07
Drug Identification Number 02475804 02475804
Brand name TARO-BUPROPION XL TARO-BUPROPION XL
Common or Proper name BUPROPION BUPROPION
Company Name SUN PHARMA CANADA INC SUN PHARMA CANADA INC
Ingredients BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE
Strength(s) 150MG 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 90 90
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Demand increase for the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-09-23 2021-09-23
Estimated end date 2022-09-30 2022-01-14
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments